perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).
Financial Statements
- Click here to download Perrigo Company plc's Income Statement
- Click here to download Perrigo Company plc's Balance Sheet
- Click here to download Perrigo Company plc's Statement of Cash Flows
Key Info
- Industry: Pharmaceutical Preparation Manufacturing
- Sector: Manufacturing
- CEO Name: Murray Kessler
Key Statistics
- Stock Price: $32.19
- Dividend Yield: 3.4000000000000004%
- Market Capitalization: $4,362,258,076
- Shares Outstanding: 135,515,939
- Number of Employees: 5,210
- Trailing 12-Month EPS: $-0.09
- Trailing 12-Month DPS: $1.08
- Payout Ratio: -1200.0%
Important Dates
- Next Earnings Date: 2024-05-07
- Next Ex-Dividend Date: 2024-03-07
Price Trends
- Current Stock Price: $32.19
- 52-week high: $39.22
- 52-week low: $25.52
- 200-day moving average: $30.49
- 50-day moving average: $30.18
Performance
- 1-Month Price Return: 23.1%
- 3-Month Price Return: 1.0%
- 6-Month Price Return: 2.7%
- 1-Year Price Return: -5.8%
- 2-Year Price Return: -10.0%
- 5-Year Price Return: -24.3%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast